evaluate the digital health company rexmd on zepbound / tirzepatide Medscape | Eli Lilly launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). device Tirzepatide Outperforms Semaglutide in Weight

Improved Blood Sugar Control : They lower blood sugar levels, reducing the likelihood of energy crashes and excessive hunger ( American Diabetes Association )

Recent Updates November 21, 2025: Updated information related to Shed

Surgical or nonoperative treatment for lumbar spinal stenosis

Key Features: FDA-approved for type 2 diabetes and cardiovascular risk reduction Available doses: 0.5mg, 1mg, and 2mg weekly Weight loss is considered an off-label benefit Wegovy: The Weight Loss Specialist Wegovy (semaglutide) injection was approved in 2021 for chronic weight management, in addition to diet and exercise, in adults with obesity or heavier body